학술논문
Manual on the proper use of the 211 At-labeled PSMA ligand ([211 At]PSMA-5) for clinical trials of targeted alpha therapy (1st edition).
Document Type
Article
Author
Source
Annals of Nuclear Medicine; May2024, Vol. 38 Issue 5, p329-336, 8p
Subject
Language
ISSN
09147187
Abstract
Copyright of Annals of Nuclear Medicine is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)